Romero-Vargas M E, Flores-Cortés M, Valera Z, Gómez-Bravo M A, Barrera-Pulido L, Pareja-Ciuró F, Serrano Díez-Canedo J, García I, Bernardos A
Servicio de Cirugía General y Digestiva, Unidad de Cirugía Hepatobiliopancreática y Trasplantes, HHUU Virgen del Rocio, Seville, Spain.
Transplant Proc. 2006 Oct;38(8):2508-10. doi: 10.1016/j.transproceed.2006.08.028.
To investigate the incidence, time of appearance, treatment, and evolution of tumors appearing in liver transplant recipients at our hospital.
We undertook a retrospective analysis of our series of liver transplants between 1990 and 2005. Patients who died during the immediate postoperative period were excluded.
Of the 515 patients, 25 died during the immediate postoperative period and therefore had no occasion to develop neoplasms. Of the remaining 490, 32 developed cancers (6.5%). The average age was 55.4 +/- 7.17 years. The reasons for transplant were alcoholic cirrhosis (n = 15), hepatitis C virus (2), hepatitis B virus (n = 1), alcoholic and viral cirrhosis (n = 7), primary biliary cirrhosis (n = 1), and cryptogenic cirrhosis (n = 1). Four patients developed multiple neoplasms. Most of the tumors were cutaneous: nine basal cell and six squamous cell carcinomas. Other locations were the lung, urothelium, stomach, thyroid, and brain. Eight patients presented metastasis at the time of diagnosis. The average tumor-free period was 3.36 years. Nine patients died as a result of the tumor.
Patients with a liver transplant have a high risk of developing cancers as a result of the immunosuppression treatment, which is lifelong. Nevertheless, other factors can be involved, such as infection by cytomegalovirus or the original diagnosis leading to transplantation. The risk for developing cancers is significantly greater than in the general population, with a higher tendency to recurrence and later development of second neoplasms.
调查我院肝移植受者中出现的肿瘤的发生率、出现时间、治疗及转归情况。
我们对1990年至2005年间我院的一系列肝移植病例进行了回顾性分析。排除术后即刻死亡的患者。
515例患者中,25例在术后即刻死亡,因此没有机会发生肿瘤。其余490例中,32例发生癌症(6.5%)。平均年龄为55.4±7.17岁。移植的原因包括酒精性肝硬化(n = 15)、丙型肝炎病毒感染(2例)、乙型肝炎病毒感染(n = 1)、酒精性和病毒性肝硬化(n = 7)、原发性胆汁性肝硬化(n = 1)和隐源性肝硬化(n = 1)。4例患者发生了多发性肿瘤。大多数肿瘤为皮肤肿瘤:9例基底细胞癌和6例鳞状细胞癌。其他部位为肺、尿路上皮、胃、甲状腺和脑。8例患者在诊断时出现转移。无瘤平均生存期为3.36年。9例患者死于肿瘤。
肝移植患者由于终身免疫抑制治疗而有发生癌症的高风险。然而,其他因素也可能起作用,如巨细胞病毒感染或导致移植的原发病诊断。发生癌症的风险明显高于普通人群,复发倾向更高,且更易发生第二肿瘤。